Sussex Research Laboratories Inc. will be closed from December 24, 2021 (Christmas Eve) to January 3rd, 2022. Thank you to our wonderful customers for your business. Happy Holidays & All the Best in 2022!

Tn Antigen: Fmoc-Ser(GalNAc(Ac)₃-α-D)-OH

Tn Antigen: Fmoc-Ser(GalNAc(Ac)₃-α-D)-OH molecular structure

Purchase

SKUPack SizeAvailabilityPriceQuantity
GA121000-25MG25mgIn StockUS$300.00
GA121000-100MG100mgIn StockUS$700.00
Inquire

Product Details

Name Tn Antigen: Fmoc-Ser(GalNAc(Ac)₃-α-D)-OH
Product No.GA121000
Synonym(s) Tn Epitope (Serine); Tn Antigen (Serine, Fmoc, Peracetylated); Fmoc-L-Ser(GalNAc(Ac)₃-α-D)-OH; Fmoc-Ser(α-D-GalNAc(Ac)₃)-OH; Fmoc-Ser(alpha-D-GalNAc(Ac)₃)-OH; N-α-Fmoc-O-β-(2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-α-D-galactopyranosyl)-L-Serine; N-(9-fluorenylmethoxycarbonyl)-O-(3,4,6-tri-O-acetyl-2-acetamido-2-deoxy-α-D-galactopyranosyl)-L-Serine
CategoryGlycoamino AcidsSerine
CAS No.120173-57-1
FormulaC32H36N2O13
Molecular Weight656.63
AvailabilityYes
Availability in BulkYes
Purity>95% (HPLC)
DescriptionTumor-Associated Carbohydrate Antigen (TACA). Tn is a truncated O-glycosylated core determinant with structure: GalNAcα-O-Ser/Thr. In normal Mamalian cells, the Tn determinant is masked by larger glycan residues. Once unmasked, Tn serves as an important recognition element, mediating several cell-cell interactions. As such, Tn is implicated in tumour cell organotropic metastasis. Targeting immune responses to truncated variants of O-glycan chains expressed by tumour cells represents a promising approach for the development of antigen-specific therapeutic vaccines against cancers, and accumulated evidence has rendered Tn a prime target for cancer immunotherapy.
CommentsN-Acetyl-D-Galactosamine; O-Link; Monosaccharide; Serine; Blocked; Amino Acid; Ac
ReferencesT. Ju, V.I. Otto and R.D. Cummings Angew. Chem. Int. Ed. 2011, 50, 1770 – 1791
Datasheet(s)GA121000_COA.pdf (85.359 KB)
‹ Back to Catalogue